Hydrochlorothiazide
- Product NDC
- 70934-930
- 11-digit product format
- 709340930
- Labeler code
- 70934
- Product ID
- 70934-930_d1f0ed23-fdb2-5295-e053-2a95a90ae9e3
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Hydrochlorothiazide
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Denton Pharma, Inc. DBA Northwind Pharmaceuticals
- Application
- ANDA203561
- Marketing category
- ANDA
- Marketing start
- 2021-11-24
- Marketing end
- 0000-00-00
- Substance
- HYDROCHLOROTHIAZIDE
- Active strength
- 13 mg/1
- Pharmacologic classes
- Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [CS]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70934-930-30 | 70934093030 | 30 CAPSULE in 1 BOTTLE, PLASTIC (70934-930-30) | 30 capsule | 2021-11-24 | 0000-00-00 | No | No | Current |
| 70934-930-90 | 70934093090 | 90 CAPSULE in 1 BOTTLE, PLASTIC (70934-930-90) | 90 capsule | 2021-11-24 | 0000-00-00 | No | No | Current |